NASDAQ: IBRX Shareholder Alert: Lawsuit Alleges Misleading Statements by ImmunityBio, Inc.
An investor, who purchased shares of ImmunityBio, Inc. (NASDAQ: IBRX), filed a lawsuit over alleged violations of Federal Securities Laws by ImmunityBio, Inc..
View full press release